Previous Article | Next Article 
Journal of Clinical Microbiology, February 1998, p. 414-420, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phenotypic and Genotypic Characterization of
Nosocomial Staphylococcus aureus Isolates from Trauma
Patients
T.
Na'was,1,2,
A.
Hawwari,1
E.
Hendrix,2
J.
Hebden,2
R.
Edelman,2
M.
Martin,3
W.
Campbell,2
R.
Naso,1
R.
Schwalbe,2 and
A.
I.
Fattom1,*
W. W. Karakawa Microbial Pathogenesis
Laboratory, NABI, Rockville, Maryland1;
School of Medicine, University of Maryland, Baltimore,
Maryland2; and
Department of
Medicine, Oregon Health Sciences University, Portland,
Oregon3
Received 5 September 1997/Returned for modification 10 October
1997/Accepted 13 November 1997
 |
ABSTRACT |
Staphylococcus aureus is a major cause of nosocomial
infections. During the period from March 1992 to March 1994, the
patients admitted to the intensive care unit of the University of
Maryland Shock Trauma Center were monitored for the development of
S. aureus infections. Among the 776 patients eligible for
the study, 60 (7.7%) patients developed 65 incidents of nosocomial
S. aureus infections. Of the clinical isolates, 43.1%
possessed a polysaccharide type 5 capsule, 44.6% possessed a type 8 capsule, and the remaining 12.3% had capsules that were not typed by
the type 5 or type 8 antibodies. Six antibiogram types were noted among
the infection-related isolates, with the majority of the types being
resistant only to penicillin and ampicillin. It was noted that the
majority of cases of pneumonia were caused by relatively susceptible
strains, while resistant strains were isolated from patients with
bacteremia and other infections. Only 16 (6.3%) of the isolates were
found to be methicillin-resistant S. aureus (MRSA). DNA
fingerprinting by pulsed-field gel electrophoresis showed 36 different
patterns, with characteristic patterns being found for MRSA strains and the strains with different capsular types. Clonal relationships were
established, and the origins of the infection-related isolates in each
patient were determined. We conclude that (i) nosocomial infection-related isolates from the shock trauma patients did not
belong to a single clone, although the predominance of a
methicillin-resistant genotype was noted, (ii) most infection-related
S. aureus isolates were relatively susceptible to
antibiotics, but a MRSA strain was endemic, and (iii) for practical
purposes, the combination of the results of capsular and antibiogram
typing can be used as a useful epidemiological marker.
 |
INTRODUCTION |
Staphylococcus aureus is
a major cause of nosocomial infections that uses numerous virulence
factors such as extracellular toxins and enzymes (13, 41).
Studies from the Centers for Disease Control and Prevention
(18) showed that during the period from 1985 to 1988, S. aureus was an important cause of postoperative wound
infections and nosocomial bacteremia and pneumonia. Current therapy for
infections due to S. aureus consists of removal of infected
devices, surgical drainage of abscesses, and the use of antibiotics
effective against the pathogen.
In the preantibiotic era S. aureus bacteremia resulted in
80% mortality (37); however, with the advent of
antibiotics, the organism was reported to be susceptible to the
earliest antimicrobial agents, the sulfonamides and penicillin. The
widespread use of these antibiotics in the 1950s induced the
predominance of
-lactamase-producing resistant strains. To solve the
problem, the
-lactamase-resistant penicillins were developed, but
reports of resistance to this new group started to appear in the 1960s
in Europe (20) and in the 1970s in the United States
(30).
The emergence of antibiotic-resistant strains of S. aureus
is now considered to be a major problem in most hospitals. Virtually, all nosocomial strains produce a
-lactamase(s) and thus are
resistant to penicillins. Moreover, data from the Centers for
Disease Control and Prevention indicate that throughout the United
States there has been an increase in the frequency of
methicillin-resistant S. aureus (MRSA) strains resistant to
multiple antibiotics in both large and small hospitals (19).
Thus far, all strains of MRSA have been susceptible to vancomycin,
although certain strains have exhibited tolerance. It is possible,
however, that vancomycin-resistant gram-positive cocci such as
Enterococcus spp. (2, 40) and Staphylococcus haemolyticus (36) may transmit the
gene(s) responsible for this phenotype to S. aureus, leaving
few if any options for antimicrobial chemotherapy of infections caused
by the organism.
Previous studies with different populations indicated that
S. aureus ranks second only to Staphylococcus
epidermidis as a cause of nosocomial bacteremia, accounting for
13% of all cases in 1988 and increasing to 19% of the total in 1990 (23). In this study we investigated the prevalence of MRSA
among isolates causing infection in patients admitted to the intensive
care unit (ICU) of the University of Maryland Shock Trauma Center
(ST-ICU). Our goal was to determine the relatedness of the patient
nasal isolates and infection-related isolates by studying their
characteristics by phenotypic methods (capsular and antibiogram typing)
and genotypic methods (pulsed-field gel electrophoresis [PFGE] of
genomic DNA) and to appraise the ability of phenotypic markers to
discriminate among strains whose identities have been confirmed by
modern strain delineation techniques based on DNA content.
 |
MATERIALS AND METHODS |
Study design and data collection.
A total of 785 patients
admitted to the Shock Trauma Center between March 1992 and March 1994 were screened for nasal carriage of S. aureus at admission.
Carriage of S. aureus was determined by obtaining swab
specimens from both anterior nares of patients at various times, as
described below. The swabs were inoculated onto 5% sheep blood agar
plates (BBL, Cockeysville, Md.), and the plates were incubated for
24 h at 35°C and observed for the growth of suspected
S. aureus colonies. After the identity of the isolates
was confirmed (6), they were stored at
70°C in freezer
vials pending further analysis.
The patients enrolled in the study were monitored daily until discharge
for the subsequent development of a nosocomial infection (bacteremia,
pneumonia, wound infection, etc.). S. aureus infections were defined as follows. Bacteremia was defined as any blood sample growing only S. aureus on culture. Pneumonia was
defined by a diagnosis of pneumonia by an attending infectious diseases
physician based upon new parenchymal abnormalities on chest radiograph
that failed to resolve with chest physical therapy; temperature,
>101°F; total leukocyte count, >10,000/mm3; abnormal
arterial-to-alveolar oxygen gradient; and an endotracheal aspirate with
>10 polymorphonuclear leukocytes per oil immersion field and numerous
gram-positive cocci in clusters; and a heavy growth of S. aureus as the predominant organism. Wound infection was defined as
fever, local cellulitis, and a purulent discharge from a wound yielding
a pure culture of S. aureus. For patients who developed
an S. aureus infection, nasal samples were recultured at the time of diagnosis. For patients who were nasal culture positive
for S. aureus on admission but who did not develop an infection, samples from the nares were routinely recultured on day 14 of hospitalization or hospital discharge, whichever was first. The
total number of S. aureus isolates recovered from the patients described above and included in the study was 254.
Capsular polysaccharide typing.
Capsular serotyping of the
coded isolates (no patient identifiers were used) was performed by
direct cell agglutination and immunoprecipitation of cell extracts as
described previously (21). Two different types of rabbit
serum samples were used to identify the capsular type of each isolate:
sera from animals vaccinated with a whole-cell vaccine (21)
and monospecific sera against either type 5 or type 8 capsular
polysaccharide conjugated vaccine prepared in rabbits (11,
12). Monoclonal antibodies to capsular types 5 and 8 produced and
standardized by NABI (Rockville, Md.) were used to confirm the capsular
serotypes of the isolates.
Antimicrobial susceptibility testing.
The susceptibilities
of all isolates to different antimicrobial agents were tested by the
disk-agar method as standardized by the National Committee for Clinical
Laboratory Standards (29). The following antimicrobial disks
and concentrations were used: ampicillin, 10 µg; cephalothin, 30 µg; clindamycin, 2 µg; erythromycin, 15 µg; oxacillin, 1 µg;
penicillin, 10 U; tetracycline, 30 µg; and vancomycin, 30 µg
(Becton Dickinson Microbiology Systems, BBL, Cockeysville, Md.). The
results were recorded after 24 h of incubation at 35°C. A
standard strain of S. aureus (ATCC 25923) was used as a
control. MRSA isolates were detected by two standard methods: by the
disk-agar diffusion susceptibility method with 1-µg oxacillin disks,
incubation at 35°C for 24 h, and inspection of the plates for
colonies after 48 h (29) and by the ability of the
isolates to grow on Mueller-Hinton agar supplemented with 4% sodium
chloride and 6 µg of oxacillin per ml (MRSA Screen Agar; BBL) after
incubation at 35°C for 24 h (25, 43).
-Lactamase production and inhibition tests.
The ability
of the isolates to produce
-lactamase was determined as recommended
by the National Committee for Clinical Laboratory Standards
(29). Confirmatory tests were performed by the disk-agar diffusion method with amoxicillin-clavulanic acid (AMC 30) and ampicillin-sulbactam (SAM 20) disks (Difco Laboratories, Detroit, Mich.), as recommended previously (29).
Genomic DNA Analysis by PFGE.
The genomic DNA was extracted
from logarithmic-phase S. aureus cultures grown in
brain heart infusion broth (BBL) as described previously by Murray et
al. (27) and modified by Wanger et al. (42). The
DNA size standards used were a bacteriophage lambda ladder consisting
of concatemers starting at 48.5 kbp and increasing to approximately
1,000 kbp (Bio-Rad Laboratories, Hercules, Calif.). The gels were
stained with ethidium bromide, rinsed, and photographed under UV light.
Statistical analysis.
Tests of statistical significance were
performed by the use of the statistical packages SAS for Windows (SAS
Institute, Cary, N.C.) and Sigma-Stat for Windows (Jandel Scientific,
San Rafael, Calif.). Means are reported as X ± 2 standard errors. Differences in proportions were tested for
significance by the chi-square test with Yate's correction or by
Fisher's exact test (for frequencies of less than 5). Differences in
means were tested for significance by Student's t test. All
P values are two-sided.
 |
RESULTS |
Demographics.
A total of 785 patients were enrolled in the
study, with the majority being males (73.3%). Most of the patients
were Caucasians (60%), followed by blacks (36%) and people of other
races (4.0%). The median age of all patients enrolled in the study was
32 years (age range, 12 to 92 years). The mean age of the patients who developed a nosocomial infection was 46.2 ± 19.6 years, while that of the patients who did not develop any infection was 37.2 ± 18.4 years. The difference between the mean ages was found to be
significant by the t test (P = 0.001). Of
the 776 patients with adequate nasal specimen cultures, 150 (19.4%)
were positive for S. aureus. Fifty-six patients (7.2%)
were reported to have acquired 65 nosocomial S. aureus
infections, namely, bacteremia (36; 55.4%), pneumonia (21; 32.3%),
and wound and other infections (8; 12.3%). Seven of the patients
developed multiple infections.
Capsular and antibiogram typing.
Among nasal carriers of
S. aureus at admission, the prevalent capsule type was
type 8 (65.9%). Among the isolates causing infections, however, there
was an almost equal prevalence of both capsular types 5 and 8 (43.1 and 44.6%, respectively). When the infections were classified by
the capsular type of the organisms causing the infection, it was found
that among the isolates causing pneumonia, S. aureus
strains of type 8 were prevalent (61.9%), while among the isolates
causing bacteremia and wound infections, type 5 isolates were more
common. Some isolates noted not to express either the type 5 or the 8 capsule (12.3%) were isolated from patients with bacteremia and wound
infections but not from patients with pneumonia (28).
Table 1 demonstrates the eight different
antibiogram types identified among the isolates tested in the study.
The data presented in Table 2 indicate
the frequency of retrieval of each of the antibiogram types at
different stages of the hospital stay, i.e., admission, infection, and
discharge. Strains of antibiogram type I were predominant at all stages
and comprised 81.5% of isolates at admission, 64% of
infection-related isolates and 65% of isolates at discharge. In
contrast, the multidrug-resistant type, type III (MRSA), comprised 0.8, 14.6, and 5.7% of isolates, respectively. Other multidrug-resistant
isolates but not MRSA, such as type II, were isolated only from
patients with infection. The retrieval of isolates with specific
antibiogram types only during certain stages of the hospital stay was
statistically valid (P = 0.002).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Antibiogram types of isolates obtained from patients
included in the study at different stages
of hospitalizationa
|
|
The S. aureus infection-related isolates were found to
have any one of six antibiogram types (Table 2). The antibiogram types of the infection-related isolates distributed by type of infection and
capsular type are presented in Table 3.
Isolates of antibiogram type I continued to be the most prevalent in
all infections (66 to 76%). The multidrug-resistant strains of
antibiogram type III were mainly isolated from patients with bacteremia
and wound infections (16.7 and 40.0%, respectively).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Summary of the antibiogram types of the infection-related
S. aureus isolates distributed by type of infection
and capsular type
|
|
Analysis of the relationship between a specific antibiogram type and
expression of a specific capsular type for all the study isolates
(Table 4) indicated that this
relationship was statistically valid (P < 0.0001) and
that there was a tendency for strains expressing a capsular type to
have only specific antibiogram patterns. It must be noted that the
number of isolates in some of the antibiograms was too small for
inclusion of the data for those isolates in the analysis.
Production of
-lactamase and methicillin resistance.
S. aureus strains capable of producing
-lactamase
were, as expected, prevalent (92.1%). Only 3 of the 20 isolates found
not to be
-lactamase producers were infection-related isolates,
constituting only 4.6% of the infection-related isolates.
Table 5 indicates the frequency of MRSA
isolates among the different isolates included in the study. Only 16 (6.3%) of the study isolates were MRSA strains, as detected by
standard methods (25, 29, 43) and confirmed by performing
the
-lactamase production and inhibition tests to ensure the
exclusion of the false-positive hyper-
-lactamase-producing strains
of S. aureus (26). The majority (81.3%) of
the MRSA isolates were found to be infection-related isolates
(infection and postinfection nasal swabs). All the MRSA strains were
significantly found to have multidrug-resistant antibiogram type III
and to possess the type 5 capsule.
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Frequency of methicillin resistance among the different
isolates obtained from patients during the studya
|
|
DNA fingerprinting.
A total of 74 S. aureus
isolates obtained from the 60 patients who suffered from infections
were fingerprinted by PFGE. In addition to the infection-related
isolates, the total represents nasal S. aureus isolates
from positive cultures of nasal specimens taken from infected patients
upon admission, infection, or discharge, when available. Of these, 32 (43.2%) expressed a type 5 capsule, 33 (44.6%) expressed a type 8 capsule, and 9 (12.2%) were not typed by the monoclonal capsular type
5 and capsular type 8 antibodies. It was notable that the percentages
of retrieval of the different capsular serotypes were not changed after
adding the data for the types of the few nasal isolates from infected
patients.
The DNA fragment patterns were stable features of the isolates and were
consistent in different DNA isolation procedures. Upon repeat
subculture, the DNA restriction patterns of the isolates did not
change. In this study a genotype was defined as any fragment pattern
which varied from another pattern with regard to the number and size of
the DNA fragments. Two or more isolates were defined as identical if
they showed analogous patterns. Types with small differences in the
fragment patterns were considered variants belonging to the same major
type (16, 35), because it was demonstrated that a single
molecular event (deletion, substitution, etc.) can potentially give
rise to mobility alterations in one to three restriction fragments
(isolates that showed patterns that differed in one to three bands were
considered genetically related but not identical
[16]). Strains having differences in more than three
bands were considered unrelated.
In total, 36 different genotypes were obtained. Figure
1 illustrates the 18 different PFGE
patterns obtained for the S. aureus isolates that expressed
the type 8 capsule. Among these the most frequent pattern was pattern
A, which was characteristic of 11 (33.3%) isolates. Figure
2 demonstrates the 16 patterns obtained for the isolates that expressed the type 5 capsule and the 3 patterns recovered for the non-type 5, non-type 8 isolates. Among the
S. aureus type 5 isolates, pattern X was the most
common pattern and was retrieved for 5 (15.6%) isolates, followed by
pattern S for 4 (12.5%) isolates and pattern Y for 3 (9.4%) isolates. Patterns E, k, and j were restricted to the non-type 5, non-type 8 S. aureus isolates. The first four patterns shown in
Fig. 2 (patterns S, T, U, and V) are the patterns obtained solely for the MRSA strains. There was minimal overlapping of the patterns between
capsular type groups; only three patterns (patterns D, F, and i)
appeared in more than one capsular type. Two patterns (patterns D and
F) overlapped between the type 5 isolates (one isolate with pattern D
and one isolates with pattern F) and the type 8 isolates (two isolates
with pattern D and one isolate with pattern F), while the third pattern
(pattern i) overlapped between the type 5 (two isolates) and the
non-type 5, non-type 8 isolates (six isolates). It was also noted that
66.7% of the non-type 5, non-type 8 isolates demonstrated pattern i
and that none of the patterns were shared by the type 5 and non-type 5, non-type 8 isolates.

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 1.
Contour-clamped homogeneous electric field
characterization of isolates by PFGE. Chromosomal DNA was digested with
the endonuclease SmaI and separated by PFGE and was then
photographed under UV light. The different patterns shown were obtained
for the isolates that expressed the type 8 capsular polysaccharide.
Lanes , size markers.
|
|

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 2.
Contour-clamped homogenous electric field
characterization of isolates by PFGE. Chromosomal DNA was digested with
endonuclease SmaI and separated by PFGE and was then
photographed under UV light. The different patterns were obtained from
the isolates that expressed the type 5 capsular polysaccharide
(patterns S to h) and the patterns obtained from the isolates denoted
as being non-type 5, non-type 8 strains (patterns i to k). Patterns S
to V represent the patterns obtained for the MRSA strains. Lane ,
size markers.
|
|
The isolates available for each S. aureus infection
episode were studied collectively, clonal relationships were
established (Fig. 3), and the origin of
the infection-related isolate from each patient was determined.
Although in most patients the profiles indicated either a
hospital-related transmission or autoinfection (due to nasal carriage),
no outbreaks were detected during the period of the study.

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 3.
Contour-clamped homogeneous electric field
characterization of isolates from bacteremic patients by PFGE.
Chromosomal DNA was digested with endonuclease SmaI and
separated by PFGE and was then photographed under UV light. The
different patterns are shown in groups for different patients to
determine strain delineation. Patterns designated a and b are those for
isolates from blood (pattern a) and nasal swab at infection (pattern b)
from patient 1; patterns designated 1, 2, 3, and 4 refer to
S. aureus isolates from patients with nasal carriage at
admission (pattern 1), infection (bacteremia) (pattern 2), infection
(gall bladder) (pattern 3), and nasal carriage at discharge (pattern
4), respectively. Lanes A, B, C, and three isolates from blood,
nasal swab at infection, and nasal swab at discharge, respectively,
from patient 3; Lane , size markers.
|
|
 |
DISCUSSION |
This study was designed to determine the prevalence of MRSA
isolates among infection-related isolates from patients admitted to the
ST-ICU, characterize the infection-related isolates phenotypically and
genotypically to determine the genetic relatedness of the organisms
involved, and evaluate whether the different typing methods are
efficient tools in routine epidemiological investigations.
Most of the S. aureus isolates retrieved in this study
(91.0%) expressed either capsular polysaccharide type 5 or capsular polysaccharide type 8 (Table 3), in compliance with previous reports
(38, 42). The relationship between nasal carriage of
S. aureus and subsequent infection has been well
established by many investigators (7, 28, 33, 41, 44).
Notably, the type 8 capsules were expressed more in the isolates from
the nares of patients at admission to the hospital, while no
significant prevalence of any of the types was noted among the
infection-related isolates. When the infections were classified by the
capsular type of the organism causing the infection, the type 5 capsular type was noted to predominate in patients with bacteremia,
while capsular type 8 was the prevalent type in patients with pneumonia (Table 3).
The antibiogram typing of the isolates revealed that antibiogram type I
(resistant only to penicillin G and ampicillin) was predominant for
73.2% of all the nasal and infection-related isolates (Table 2). This
result reflects the predominance of relatively susceptible strains in
our setting. The retrieval of more resistant strains among the
infection-related isolates was expected (Table 3). An interesting
finding was not only that some isolates with specific antibiogram types
expressed a specific type of capsule (all type III isolates had a type
5 capsule) but also that there existed a significant relationship
(P < 0.0001) between the recovery of certain
antibiogram types from isolates with a specific capsular type (Table
4).
Of the isolates tested, 6.3% were found to be resistant to
methicillin. The results presented in Table 5 indicate that most of the
MRSA isolates are infection-related isolates, implying that MRSA is
present in a reservoir in the hospital environment. The finding that
only 16.7% of the bacteremias in this study were caused by MRSA
reflected a proper hospital management plan for MRSA, because MRSA
comprised 20% of all isolates causing bacteremia at the University of
Maryland Hospital in 1988, a proportion that increased dramatically to
50% in 1990 (23).
Our study disclosed a significant relationship between the property of
methicillin resistance and the possession of a specific type of
capsule. All our MRSA isolates (100%) possessed a type 5 capsule, in
agreement with previous reports noting the prevalence of type 5 capsules in MRSA isolates (5, 14, 42).
The finding that most infection-related S. aureus
isolates belonged to capsular polysaccharide type 5 or 8 did not
signify whether these strains were derived from resident (patient),
commensal isolates or were the result of the nosocomial spread of a
single endemic strain. To perform proper epidemiological typing and
delineation of genetic relatedness, a number of methods were introduced
and used effectively by other investigators. These methods included bacteriophage typing (22, 44), plasmid pattern analysis
(4, 8), whole-cell protein profile analysis (9),
immunoblotting profile analysis (15), ribotyping (10,
39), restriction endonuclease analysis of plasmid DNA (17,
34), and PFGE of restriction enzyme-digested genomic DNA (1,
24, 32). We chose to use PFGE for our study because the
exceptional properties of PFGE have, with time, turned it into a
favored epidemiological tool (3, 27, 31). PFGE detects the
distribution of restriction sites throughout the chromosome, giving
fingerprints that reflect the structural organization of the bacterial
chromosome (31). This distribution of restriction sites,
which varies because of ancestral strain-to-strain mutational
differences and because of the variations in the gene content of the
staphylococcal chromosome, give the method its acknowledged
discriminatory ability.
The DNA components of all of the isolates from infected patients were
fingerprinted by PFGE. Each of the genotypes obtained by PFGE of DNA
for the S. aureus isolates tested was given a different designation, without consideration of band differences and relatedness, in order to present large numbers of patterns, as was previously done
by others (31, 35). Except for the few exceptions mentioned previously, the 36 patterns obtained were clearly separated on the
basis of capsular type. The isolates that expressed the type 8 capsular
polysaccharide were found to have to a specific set of patterns (Fig.
1), while those that expressed the type 5 capsular polysaccharide had a
different set of patterns (Fig. 2). The isolates that did not produce
either the type 5 or the type 8 capsule were found to have one of three
patterns (patterns i, j, and k in Fig. 2). An interesting result was
the finding that the MRSA isolates that were found to produce a type 5 capsule had one of only four possible patterns that were not shared by
any of the other isolates that produced type 5 patterns (patterns S to
V in Fig. 2), with pattern S being the most prevalent (56.3%). This
finding confirmed the clonal relatedness of the MRSA strains isolated
in the study.
Figure 3 presents the PFGE patterns for MRSA isolates from three
different bacteremic patients. The data demonstrate the clonal relationships of these isolates. Isolates from the same patient had
identical DNA patterns. Furthermore, isolates from the different patients had similar patterns (a difference of only one or two bands).
These data establish the presence of a resident MRSA population endemic
in our setting, probably as nosocomial colonization of hospital
personnel. This finding is a reasonable incentive for initiating an
infection control study that aims at detecting and treating MRSA
carriers in shock trauma units.
PFGE demonstrated typeability, reproducibility, and an ability to
discriminate between strains. These properties demarcate an excellent
tool for epidemiological studies; however, the only problem with the
routine use of this method is the difficulty in performing the
technique and the need for expensive instruments and chemicals.
The trend toward developing precise molecular biology-based methods has
diverted attention from the development of simpler and more common
typing methods (like capsular and antibiogram typing techniques).
Attempts were made to use a combination of antibiogram and capsular
typing methods, both of which are simple techniques that are routinely
performed in many hospitals, to assess the possibility of using them as
discriminatory tools for epidemiological studies. For practical
purposes, the epidemiological conclusions based on the results of the
tests based on the use of the previous combination of methods
correlated well with those based on the use of the DNA fingerprinting
by PFGE, especially with regard to the MRSA isolates.
The previous results indicated the possibility of using the two typing
methods in combination in order to provide a more effective tool for
epidemiological studies. Because antibiogram typing has been used as an
effective tool in associating isolates to outbreaks in hospitals
(42) and because both capsular typing and antibiogram typing
are easy and reproducible techniques, we suggest that a combination of
these simple typing methods be used for the routine processing of
clinical specimens in hospitals, because the results obtained may
provide valuable epidemiological information. However, we suggest
increasing the number of antibiotics used in antibiogram typing,
because this will increase the technique's potential for discrimination.
We conclude that (i) the nosocomial infection isolates from the shock
trauma patients were not found to belong to a single clone, although
the predominance of one methicillin-resistant genotype was noted. (ii)
Most S. aureus infections were caused by organisms
relatively susceptible to antibiotics, although a well-defined
multidrug resistant hospital strain of MRSA was present in our setting.
(iii) For practical purposes, we suggest the use of a combination of
the results of capsular and antibiogram typing as an
epidemiological marker, based on the fact that in our study the
combined results correlated well with those based on the use of the DNA
fingerprinting by PFGE.
 |
ACKNOWLEDGMENT |
T. Na'was was a visiting researcher from the Faculty of
Medicine of the Jordan University of Science and Technology supported by a Fulbright grant sponsored by the United States Information Agency.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: NABI Rockville,
12280 Wilkins Ave., Rockville, MD 20852. Phone: (301) 255-6970. Fax: (301) 770-2014. E-mail: afattom{at}nabi.com.
Present address: Natural Science Division, Lebanese American
University, Beirut, Lebanon.
 |
REFERENCES |
| 1.
|
Allardet-Servent, A.,
N. Bouziges,
M. J. Carles-Nurit,
G. Bourg,
A. Gouby, and M. Ramuz.
1989.
Use of low-frequency-cleavage restriction endonucleases for DNA analysis in epidemiological investigations of nosocomial bacterial infections.
J. Clin. Microbiol.
27:2057-2061[Abstract/Free Full Text].
|
| 2.
|
Al-Obeid, S.,
E. Collatz, and L. Gutman.
1990.
Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus fecalis A256.
Antimicrob. Agents Chemother.
34:252-256[Abstract/Free Full Text].
|
| 3.
|
Arbeit, R. D.,
M. Mathur,
R. Dunn,
C. Kim,
R. K. Selander, and R. Goldstein.
1990.
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed-field electrophoresis to molecular epidemiology.
J. Infect. Dis.
161:230-235[Medline].
|
| 4.
|
Archer, G. L., and C. G. Mayhall.
1983.
Comparison of epidemiological markers used in the investigation of an outbreak of methicillin-resistant Staphylococcus aureus infections.
J. Clin. Microbiol.
18:395-399[Abstract/Free Full Text].
|
| 5.
|
Boutonnier, A.,
F. Nato,
A. Bouvet,
L. Lebrun,
A. Audurier,
J. C. Mazie, and J. M. Fournier.
1989.
Direct testing of blood cultures for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus.
J. Clin. Microbiol.
27:989-993[Abstract/Free Full Text].
|
| 6.
|
Chambers, H. F., and C. J. Hackbarth.
1987.
Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
31:1982-1988[Abstract/Free Full Text].
|
| 7.
|
Chow, J. W., and V. L. Yu.
1989.
Staphylococcus aureus nasal carriage in hemodialysis patients.
Arch. Intern. Med.
149:1258-1262[Abstract].
|
| 8.
|
Collins, J. K.,
J. S. Smith, and M. T. Kelly.
1984.
Comparison of phage typing, plasmid mapping, and antibiotic resistance patterns as epidemiologic markers in a nosocomial outbreak of methicillin-resistant Staphylococcus aureus infections.
Diagn. Microbiol. Infect. Dis.
2:233-245[Medline].
|
| 9.
|
Costas, M.,
B. D. Cookson,
H. G. Talsania, and R. J. Owen.
1989.
Numerical analysis of electrophoresis protein patterns of methicillin-resistant strains of Staphylococcus aureus.
J. Clin. Microbiol.
27:2574-2581[Abstract/Free Full Text].
|
| 10.
|
De Buyser, M. L.,
A. Morvan,
F. Grimont, and N. El-Solh.
1989.
Characterization of Staphylococcus aureus species by ribosomal gene restriction patterns.
J. Gen. Microbiol.
135:989-999[Medline].
|
| 11.
|
Fattom, A.,
R. Schneerson,
S. C. Szu,
W. F. Vann,
J. Shiloach,
W. W. Karakawa, and J. B. Robbins.
1990.
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
Infect. Immun.
58:2367-2374[Abstract/Free Full Text].
|
| 12.
|
Fattom, A.,
R. Schneerson,
D. C. Watson,
W. W. Karakawa,
D. Fitzgerald,
I. Pastan,
X. Li,
J. Shiloach,
D. A. Bryla, and J. B. Robbins.
1993.
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
Infect. Immun.
61:1023-1032[Abstract/Free Full Text].
|
| 13.
|
Foster, T. J.
1991.
Potential for vaccination against infections caused by Staphylococcus aureus.
Vaccine
9:221-227[Medline].
|
| 14.
|
Fournier, J. M.,
A. Bouvet,
A. Boutonnier,
A. Audurier,
F. Goldstein,
J. Pierre,
A. Bure,
L. Lebrun, and H. K. Hochkeppel.
1987.
Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus.
J. Clin. Microbiol.
25:1932-1933[Abstract/Free Full Text].
|
| 15.
|
Gaston, M. S.,
P. S. Duff,
J. Naidoo,
K. Ellis,
J. I. S. Roberts,
J. F. Richardson,
R. R. Marples, and E. M. Cooke.
1988.
Evaluation of electrophoretic methods for typing methicillin-resistant Staphylococcus aureus.
J. Med. Microbiol.
26:189-197[Abstract].
|
| 16.
|
Goering, R. V., and the Molecular Epidemiological Study Group.
1994.
Guidelines for evaluating pulsed-field restriction fragment patterns in the epidemiological analysis of nosocomial infections, abstr. F19.
In
Third International Meeting of Bacterial Epidemiological Markers, Cambridge, England.
|
| 17.
|
Hartsein, A. I.,
V. H. Morthland,
S. Eng,
G. L. Archer,
F. D. Schoenknecht, and A. L. Rashad.
1989.
Restriction enzyme analysis of plasmid DNA and bacteriophage typing of paired Staphylococcus aureus blood culture isolates.
J. Clin. Microbiol.
27:1874-1879[Abstract/Free Full Text].
|
| 18.
|
Horan, T.,
D. Culver,
W. Jarvis, et al.
1988.
Pathogens causing nosocomial infections: preliminary data from the national nosocomial infections surveillance system.
Antimicrob. Newsl.
5:65-67.
|
| 19.
|
Hughes, J. M.
1987.
Setting priorities: nationwide nosocomial infection prevention and control programs in the USA.
Eur. J. Clin. Microbiol.
6:348-351[Medline].
|
| 20.
|
Jessen, O.,
K. Rosendal,
P. Bülow,
V. Faber, and K. R. Eriksen.
1969.
Changing staphylococci and staphylococcal infections: a ten-year study of bacteria and cases of bacteremia.
N. Engl. J. Med.
281:627-635.
|
| 21.
|
Karakawa, W. W.,
J. M. Fournier,
W. F. Vann,
R. Arbeit,
R. S. Schneerson, and J. B. Robbins.
1985.
Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus.
J. Clin. Microbiol.
22:445-447[Abstract/Free Full Text].
|
| 22.
|
Luzar, M. A.,
G. A. Coles,
B. Faller,
A. Slingeneyer,
G. DahDah,
C. Briat,
C. Wone,
Y. Knefati,
M. Kessler, and F. Peluso.
1990.
Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
N. Engl. J. Med.
322:505-509[Abstract].
|
| 23.
| Martin, M. A. Unpublished data.
|
| 24.
|
McClelland, M.,
R. Y. Jones, and M. Nelson.
1987.
Restriction endonucleases for pulsed field mapping of bacterial genomes.
Nucleic Acids Res.
15:5985-6005[Abstract/Free Full Text].
|
| 25.
|
McDougal, L. K., and C. Thornsberry.
1984.
New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.
J. Clin. Microbiol.
19:482-488[Abstract/Free Full Text].
|
| 26.
|
McDougal, L. K., and C. Thornsberry.
1986.
The role of -lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
J. Clin. Microbiol.
23:832-839[Abstract/Free Full Text].
|
| 27.
|
Murray, B. E.,
K. V. Singh,
J. D. Heath,
B. R. Sharma, and G. M. Weinstock.
1990.
Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.
J. Clin. Microbiol.
28:2059-2063[Abstract/Free Full Text].
|
| 28.
| Na'was, T., A. Hawwari, E. Hendrix, J. Hebden, R. Edelman, M. Martin, W. Campbell, R. Naso, R. Schwalbe, and A. Fattom. Submitted for publication.
|
| 29.
|
National Committee for Clinical Laboratory Standards.
1993.
Approved standard M2-A5. Performance standards for antimicrobial disk susceptibility tests, 5th ed.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 30.
|
Peacock, J. E., Jr.,
F. J. Marsik, and R. P. Wenzel.
1980.
Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital.
Ann. Intern. Med.
93:526-532.
|
| 31.
|
Prevost, G.,
B. Jaulhac, and Y. Piemont.
1992.
DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates.
J. Clin. Microbiol.
30:967-973[Abstract/Free Full Text].
|
| 32.
|
Prevost, G.,
B. Pottecher,
M. Dahlet,
M. Bientz,
J. M. Mantz, and Y. Piemont.
1991.
Pulsed-field gel electrophoresis as a new epidemiological tool for monitoring methicillin-resistant Staphylococcus aureus in an intensive care unit.
J. Hosp. Infect.
17:255-269[Medline].
|
| 33.
|
Raviglione, M. C.,
P. Mariuz,
A. Pablos-Mendez,
R. Battan,
P. Ottuso, and A. Taranta.
1990.
High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS related complex.
Am. J. Infect. Control
18:64-69[Medline].
|
| 34.
|
Rhinehart, E.,
D. M. Shlaes,
T. F. Keys,
J. Serkey,
B. Kirkley,
C. Kim,
C. A. Currie-McCumber, and G. Hall.
1987.
Nosocomial clonal dissemination of methicillin-resistant Staphylococcus aureus.
Arch. Intern. Med.
92:7-13.
|
| 35.
|
Schlichting, C.,
C. Branger,
J.-M. Fournier,
W. Witte,
A. Boutonnier,
C. Wolz,
P. Goullet, and G. Döring.
1993.
Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.
J. Clin. Microbiol.
31:227-232[Abstract/Free Full Text].
|
| 36.
|
Schwalbe, R. S.,
J. S. Stapleton, and P. H. Gilligan.
1987.
Emergence of vancomycin resistance in coagulase-negative staphylococci.
N. Engl. J. Med.
316:927-931[Medline].
|
| 37.
|
Smith, I. M., and A. B. Vickers.
1960.
Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955).
Lancet
i:1318-1322.
|
| 38.
|
Sompolonsky, D.,
Z. Samra,
W. W. Karakawa,
W. F. Vann,
R. Schneerson, and Z. Malik.
1985.
Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.
J. Clin. Microbiol.
22:828-834[Abstract/Free Full Text].
|
| 39.
|
Thomson-Carter, F. M.,
P. E. Carter, and T. H. Pennington.
1989.
Differentiation of Staphylococcus aureus species and strains by ribosomal RNA gene patterns.
J. Gen. Microbiol.
135:2093-2097[Medline].
|
| 40.
|
Uttley, A. H.,
R. C. George,
J. Naidoo,
N. Woodford,
A. P. Johnson,
C. H. Collins,
D. Morrison,
A. J. Gilfillan,
L. E. Fitch, and J. Heptonstall.
1989.
High level vancomycin-resistant enterococci causing hospital infections.
Epidemiol. Infect.
103:173-181[Medline].
|
| 41.
|
Waldvogel, F. A.
1990.
Staphylococcus aureus. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practices of infectious disease, 3rd ed.
Churchill Livingstone, New York, N.Y.
|
| 42.
|
Wanger, A. R.,
S. L. Morris,
C. Ericsson,
K. V. Singh, and M. T. LaRocco.
1992.
Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods.
J. Clin. Microbiol.
30:2583-2588[Abstract/Free Full Text].
|
| 43.
|
Working Party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy.
1986.
Guidelines for the control of epidemic methicillin resistant Staphylococcus aureus.
J. Hosp. Infect.
7:193-201[Medline].
|
| 44.
|
Yu, V. L.,
A. Goetz,
M. Wagener,
P. B. Smith,
J. D. Rihs,
J. Hanchett, and J. J. Zuraleff.
1986.
Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis.
N. Engl. J. Med.
315:91-96[Abstract].
|
Journal of Clinical Microbiology, February 1998, p. 414-420, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tuchscherr, L. P. N., Gomez, M. I., Buzzola, F. R., Calvinho, L. F., Lee, J. C., Sordelli, D. O.
(2007). Characterization of a New Variant of IS257 That Has Displaced the Capsule Genes within Bovine Isolates of Staphylococcus aureus. Infect. Immun.
75: 5483-5488
[Abstract]
[Full Text]
-
Verdier, I., Durand, G., Bes, M., Taylor, K. L., Lina, G., Vandenesch, F., Fattom, A. I., Etienne, J.
(2007). Identification of the Capsular Polysaccharides in Staphylococcus aureus Clinical Isolates by PCR and Agglutination Tests. J. Clin. Microbiol.
45: 725-729
[Abstract]
[Full Text]
-
Revazishvili, T., Bakanidze, L., Gomelauri, T., Zhgenti, E., Chanturia, G., Kekelidze, M., Rajanna, C., Kreger, A., Sulakvelidze, A.
(2006). Genetic Background and Antibiotic Resistance of Staphylococcus aureus Strains Isolated in the Republic of Georgia.. J. Clin. Microbiol.
44: 3477-3483
[Abstract]
[Full Text]
-
Lee, L. Y. L., Liang, X., Hook, M., Brown, E. L.
(2004). Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb). J. Biol. Chem.
279: 50710-50716
[Abstract]
[Full Text]
-
Cunnion, K. M., Hair, P. S., Buescher, E. S.
(2004). Cleavage of Complement C3b to iC3b on the Surface of Staphylococcus aureus Is Mediated by Serum Complement Factor I. Infect. Immun.
72: 2858-2863
[Abstract]
[Full Text]
-
Stranden, A., Frei, R., Widmer, A. F.
(2003). Molecular Typing of Methicillin-Resistant Staphylococcus aureus: Can PCR Replace Pulsed-Field Gel Electrophoresis?. J. Clin. Microbiol.
41: 3181-3186
[Abstract]
[Full Text]
-
Khatib, R., Sharma, M., Naqvi, S. A. H., Riederer, K., Almoujahed, M. O., Fakih, M. G.
(2003). Molecular Analysis of Staphylococcus aureus Blood Isolates Shows Lack of Polyclonal Bacteremia. J. Clin. Microbiol.
41: 1717-1719
[Abstract]
[Full Text]
-
Cunnion, K. M., Frank, M. M.
(2003). Complement Activation Influences Staphylococcus aureus Adherence to Endothelial Cells. Infect. Immun.
71: 1321-1327
[Abstract]
[Full Text]
-
Cunnion, K. M., Zhang, H.-M., Frank, M. M.
(2003). Availability of Complement Bound to Staphylococcus aureus To Interact with Membrane Complement Receptors Influences Efficiency of Phagocytosis. Infect. Immun.
71: 656-662
[Abstract]
[Full Text]
-
Shirtliff, M. E., Mader, J. T.
(2002). Acute Septic Arthritis. Clin. Microbiol. Rev.
15: 527-544
[Abstract]
[Full Text]
-
Montesinos, I., Salido, E., Delgado, T., Cuervo, M., Sierra, A.
(2002). Epidemiologic Genotyping of Methicillin-Resistant Staphylococcus aureus by Pulsed-Field Gel Electrophoresis at a University Hospital and Comparison with Antibiotyping and Protein A and Coagulase Gene Polymorphisms. J. Clin. Microbiol.
40: 2119-2125
[Abstract]
[Full Text]
-
Shinefield, H., Black, S., Fattom, A., Horwith, G., Rasgon, S., Ordonez, J., Yeoh, H., Law, D., Robbins, J. B., Schneerson, R., Muenz, L., Fuller, S., Johnson, J., Fireman, B., Alcorn, H., Naso, R.
(2002). Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis. NEJM
346: 491-496
[Abstract]
[Full Text]
-
Cunnion, K. M., Lee, J. C., Frank, M. M.
(2001). Capsule Production and Growth Phase Influence Binding of Complement to Staphylococcus aureus. Infect. Immun.
69: 6796-6803
[Abstract]
[Full Text]
-
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., Spratt, B. G.
(2000). Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones of Staphylococcus aureus. J. Clin. Microbiol.
38: 1008-1015
[Abstract]
[Full Text]
-
Marcos, J. Y., Soriano, A. C., Salazar, M. S., Moral, C. H., Ramos, S. S., Smeltzer, M. S., Carrasco, G. N.
(1999). Rapid Identification and Typing of Staphylococcus aureus by PCR-Restriction Fragment Length Polymorphism Analysis of the aroA Gene. J. Clin. Microbiol.
37: 570-574
[Abstract]
[Full Text]